🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Edjay R. Hernandez

ORCID: 0000-0001-8129-8109

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies”.

Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies

American Journal of Medical Genetics Part A(2020)10.1002/ajmg.a.61485

N/A

0DataRank · unranked

63 citations

Megan N. Frone, Karen W. Gripp, Bruce D. Gelb, Lisa Schoyer, Lisa Schill +17 more

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0525

N/A

0DataRank · unranked

20 citations

Xiaolin Wan, Edjay R. Hernandez, Ruibai Luo, Gaelyn C. Lyons, Kelli M. Wilson +17 more

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

Cancers(2024)10.3390/cancers16132320

N/A

0DataRank · unranked

6 citations

Jacob S. Roth, Edjay R. Hernandez, Joshua T. Kowalczyk, Nancy E. Sealover, Katie E. Hebron +17 more

Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0022

N/A

0DataRank · unranked

2 citations

Stacey Stauffer, Hyun Lee, Kristine A. Isanogle, Ying Wu, Katie Powell +17 more